News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 11.19.18

Monday November 19, 2018
Reprogrammed Stem Cells Implanted into Patient with Parkinson’s
Scientific American
In October, neurosurgeon Takayuki Kikuchi at Kyoto University Hospital implanted 2.4 million dopamine precursor cells into the brain of a patient in his 50s. In the three-hour procedure, Kikuchi’s team deposited the cells into 12 sites, known to be centres of dopamine activity. Dopamine precursor cells have been shown to improve symptoms of Parkinson’s in monkeys.
Parkinson's: Scientists Find New Target to Destroy Protein Clumps
Medical News Today
Blocking an enzyme could put a stop to the buildup of toxic protein clumps that occurs in the brains of people with Parkinson's. Scientists at Georgetown University Medical Center (GUMC) in Washington, D.C. reached this conclusion after studying the enzyme, called USP13, in the brains of mice and humans.
Parkinson's and the Gut Microbiome
with Novel Immunotherapy for Parkinson's
News-Medical Life Sciences
Many studies have focused on the possibility that the gut microbiome is connected to the development of Parkinson’s. Specifically, gut bacteria are thought to play a role in Parkinson's development. One study, for instance, has shown that increased numbers of gut microbial taxa are found in the stools of patients with Parkinson’s compared with healthy controls.
CDC Selects Parkinson's as One of the First Diseases
Included in New Database
Foxfeed Blog
A new database at the Centers for Disease Control (CDC) will collect vital demographic information on people living with neurological diseases. Earlier this fall, Congress gave the CDC funds to implement this database, called the National Neurological Conditions Surveillance System (NNCSS). The CDC recently announced that Parkinson's is one of two diseases that will be included in the initial rollout of the NNCSS.